MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2021.08.058

Медицинская библиотека · Transplantation proceedings · 2021

Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C.

Arias Ana Belén Vico, Villegas Herrera María Trinidad, Arco Sánchez Alba, Adel Moisés El, Triguero Cabrera Jennifer, Plata Illescas Cristina, Montes Osuna Maria Carmen, Santoyo Villalba Julio, Villar Del Moral Jesús María

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The development of new direct-acting antivirals (DAA) for hepatitis C virus (HCV) treatment has reduced the indications for liver transplantation (LT). We analyzed the indications, characteristics, and evolution of patients with HCV infection who were treated with DAA-based therapies and who underwent LT.

MATERIAL AND

METHODS

A retrospective single-center study was performed. Data were collected of patients undergoing LT owing to HCV infection between January 2016 and August 2020. Overall characteristics of the patients were analyzed and divided into 2 groups according to the indication for LT: hepatocellular carcinoma (HCC) or decompensated cirrhosis (DC). Differences between biliary and vascular complications after surgery and survival time were compared.

RESULTS

Of 156 LTs, 33 (22%) were performed in patients with HCV infection in this period, which shows a decrease of nearly 16% when comparing this period with the interferon/ribavirin era. Indications for LT were 56.7% in patients with HCC and 43.3% in patients with DC. After DAA treatment, all patients developed a sustained viral response. Mean age of the global series, HCC group, and DC group were 56.9, 58.71, and 54.4 years, respectively (P = .041); 53.8% of the HCV-DC group initiated DAA treatment by the time to be included at the waiting list, compared with 17.6% of HCV-HCC group (P = .045). There were no statistically significant differences in terms of survival or biliary and vascular complications after LT.

CONCLUSION

Patients with HCV are still part of the waiting list, mainly because of HCC. No statistical differences were shown in terms of postoperative complications or survival. Studies with a higher number of patients are needed.

Для цитирования: Arias Ana Belén Vico, Villegas Herrera María Trinidad, Arco Sánchez Alba, Adel Moisés El, Triguero Cabrera Jennifer, Plata Illescas Cristina, Montes Osuna Maria Carmen, Santoyo Villalba Julio, Villar Del Moral Jesús María. Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C.. Transplantation proceedings. 2021. DOI: 10.1016/j.transproceed.2021.08.058.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.